Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis (Q43652159)

25 November 2017

title

Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis (English)

1 reference

25 November 2017

Kontny HU

1 reference

25 November 2017

Hämmerle K

1 reference

25 November 2017

Klein R

1 reference

25 November 2017

Shayan P

1 reference

25 November 2017

Mackall CL

1 reference

25 November 2017

Niemeyer CM

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Cell Death & Differentiation

25 November 2017

published in

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

506-514

1 reference

Biology of pediatric peripheral neuroectodermal tumors

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Characterization of two receptors for TRAIL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Fas (APO-1, CD95)-Mediated Apoptosis in Thyroid Cells Is Regulated by a Labile Protein Inhibitor*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400836

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4400836

1 reference

Dimensions Publication ID

25 November 2017

1043232933

0 references

Fatcat ID

release_32t35dflejhjllwjvk4y5vzcoy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/32t35dflejhjllwjvk4y5vzcoy

24 November 2022

mapped directly with Wikidata item

1 reference